Advertisement

Topics

BIO.COM Company Profile

13:59 EDT 18th September 2018 | BioPortfolio

The life science research community is a uniquely vital component of our society. Those dedicated to gaining an understanding of fundamental biological processes appreciate its profundity and, along with the casual observer, are aware of its value to an improved quality of life. Bio.com exists to create a distributed, online community of scientists, professionals, businesses and organizations supporting the life sciences for the purpose of facilitating communications and disseminating information within that community. Opening channels of information can only benefit those who strive to contribute to these endeavors, and we are very pleased to have an opportunity to participate.
Bio.com is the successor to BRNI, an Internet project initiated in early 1992. At that time, the Internet was used solely for research purposes and I had no preconception that its use would become as wide-spread and general as it is today. In retrospect, it's difficult for even me to recall that we were one of only 50 websites that existed worldwide in 1992. We've watched the rise and fall of the "dot.com" boom and have proudly remained true to our cause through it all. It has been a challenge for us to grow and adapt to the rapidly changing Internet environment, and it often seems that our long-range plans change weekly. Consequently, Bio.com continues to be a work in progress-with dynamic goals and dimensions. Please utilize and judge Bio.com accordingly.

We solicit your participation. Your comments, suggestions and criticisms are invited. We are open to discussing collaborations with other organizations and motivated individuals. Oddly, despite the large number of professionals using Bio.com, we do not receive the level of feedback we desire. It amazes me how our acceptance has grown to the point that we seem to be somewhat taken for granted. Perhaps the best indication of this is the sudden response we get whenever a server goes down.

Bio.com is a commercial enterprise, owned and operated by BIO.COM. We are not funded by the government and have not requested any form of tax-exempt status. We believe that free enterprise affords us the greatest latitude to pursue our goals with the least compromise due to bureaucracies and politics. In effect, we are willing to allow our success to be based on the value we yield. And, we continue to grow as we enter our 10th year in business.

Why do we quote the Tao? It is a simple reminder that our purpose is not to change the world, but to be a part of it. To that end, we feel that we've been very successful as our participation and contributions are beyond dispute

Location

1900 Powell StreetSuite 230
Emeryville
California
94608
United States of America

Contact

Phone: (510) 601-7194
Fax: (510) 601-1862
Email: corp@bio.com


News Articles [425808 Results]

Aeglea BioTherapeutics Announces Positive Clinical Updates

While some companies wait until clinical trials are finished with dosing and collecting data to begin releasing information, those that release interim data can give investors a better handle on how t...

Pigment Epithelium Derived Factor: Characterization, Genomic Organization and Sequence of PEDF Gene

Retinal pigment epithelium (RPE) cells secrete a unique 50 kD protein. This protein, pigment epithelium-derived factor (PEDF), contains trophic activity in both the induction of neuronal cell differen...

Pigment Epithelium Derived Factor: Characterization of Its Novel Biological Activity and Sequences Encoding and Expressing the Protein

Pigment epithelium-derived factor (PEDF), a unique 50 kD protein secreted by retinal pigment epithelium (RPE) cells, has trophic activity. This invention describes the biological activity of PEDF, a m...

AAV4 Vector And Uses Thereof

These patent applications describe the cloning and characterization of the full-length genome of adeno-associated virus type 4 (AAV4). AAV4, like other members of the AAV family, may be useful as a ve...

Virally Mediated Gene Therapy For The Control Of Chronic Or Persistent Pain

Current treatments for pain, especially chronic pain, are only partially effective and can eventually involve procedures that are invasive or associated with unacceptable side effects. In vivo gene tr...

Method of Diagnosing Multidrug Resistant Tuberculosis

The invention can be used to develop tests that are much more rapid than conventional tests for determining drug resistance. It relates to the discovery that a putative gene of Mycobacterium tuberculo...

Ocular Therapeutic Agent Delivery Devices And Methods

The invention is directed to ocular implant devices for the delivery of therapeutic agents to the eye in a controlled and sustained manner. Implants suitable for either subconjunctival or intravitrea...

Parallel Measurements of Multiple Macromolecules Using a Cryoarray

Available for license is a new improved technique for the creation of biological arrays of 25-100 biological samples per slide, for use in parallel molecular screening in medical research and clinical...

PubMed Articles [1000003 Results]

Novel C-ring analogs of ursolic acid: synthesis and cytotoxic evaluation.

Ursolic acid (1), a natural pentacyclic triterpenic acid, afforded a variety of ring-C transformed products (5-11) when treated with N-bromosuccinimide under the influence of a range of protective gro...

Chemical constituents of Tilia taquetii leaves and their inhibition of MMP-1 expression and elastase activities.

The ethanol extract of Tilia taquetii Schneider leaves was investigated for its anti-wrinkle properties and for the relevant chemical constituents. Phytochemical studies led to the identification of f...

Ent-Kaurane diterpenes from Annona glabra and their cytotoxic activities.

A new ent-kaurane glycoside, annoglabasin H (1), and three known ent-kauranes, annoglabasin E (2), annoglabasin B (3), and 19-nor-ent-kaurent-4-ol-17-oic acid (4) were isolated from the fruits of Anno...

Isolation and structural characterization of a new minor diterpene glycoside from Stevia rebaudiana.

From the commercial extract of the leaves of the sweet plant Stevia rebaudiana Bertoni obtained from Sinochem Qingdao Co. Ltd., a new diterpene glycoside having three β-D-glucopyranosyl units of whic...

Two new aromadendrane sesquiterpenes from the stem bark of Alafia multiflora.

Two new aromadendrane sesquiterpenoids (1β,4β,5β,6α,7α,11S)-aromadendr-9-en-13,14-dioic acid (1) and (1β,4β,5β,6α,7α,11S)-13-oxoaromadendr-9-en-14-oic acid (2) have been isolated from the st...

Clinical Trials [155725 Results]

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...

Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment

Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...

Companies [54802 Results]

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

Schiff Nutrition International, Inc.

Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United S...

Fero Industries, Inc.

Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market poten...

Water Pik, Inc.

Water Pik is a leading developer, manufacturer and marketer of innovative personal healthcare products sold under the Waterpik® brand name. The Company has developed and introd...

More Information about "BIO.COM" on BioPortfolio

We have published hundreds of BIO.COM news stories on BioPortfolio along with dozens of BIO.COM Clinical Trials and PubMed Articles about BIO.COM for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BIO.COM Companies in our database. You can also find out about relevant BIO.COM Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record